Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06271577Not ApplicableRecruiting

Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

Role: lead

NCT03515083Not ApplicableCompleted

Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm

Role: collaborator

NCT03557034Not ApplicableCompleted

A Fib Clinic of the Future Using KardiaPro Platform for Chronic Care of Patients With AF After Ablation Procedure

Role: collaborator

NCT03037229Completed

Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction

Role: collaborator

NCT02214069Completed

Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation

Role: collaborator

All 5 trials loaded